Latest Breaking News On - Contact ultragenyx pharmaceutical inc - Page 1 : comparemela.com

Ultragenyx Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants

NOVATO, Calif., June 12, 2024 (GLOBE NEWSWIRE) Ultragenyx

United statesNew yorkJoshua higaUltragenyx pharmaceuticalincTd securities united statesJp morgan securitiesGoldman sachs coExchange commissionBroadridge financial solutionsProspectus departmentContact ultragenyx pharmaceutical incExchange commission onGoldman sachsBofa securitiesIsland avenueTryon street

Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

NOVATO, Calif., Oct. 18, 2023 Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases,.

New yorkUnited statesJoshua higaGoldman sachs coJp morgan securitiesExchange commissionUltragenyx pharmaceutical incBroadridge financial solutionsExchange commission onContact ultragenyx pharmaceutical incProspectus departmentGoldman sachsBofa securitiesIsland avenueTryon streetPrivate securities litigation reform act

Ultragenyx Announces Pricing of Public Offering of Common

NOVATO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development.

New yorkUnited statesJoshua higaJp morgan securitiesGoldman sachs coUltragenyx pharmaceutical incExchange commissionExchange commission onContact ultragenyx pharmaceutical incBroadridge financial solutionsProspectus departmentGoldman sachsBofa securitiesIsland avenueTryon streetPrivate securities litigation reform act

Ultragenyx Announces Proposed Public Offering of Common Stock

NOVATO, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases,

New yorkUnited statesJoshua higaGoldman sachs coJp morgan securitiesProspectus departmentContact ultragenyx pharmaceutical incUltragenyx pharmaceutical incBroadridge financial solutionsExchange commission onExchange commissionGoldman sachsBofa securitiesIsland avenueTryon streetPrivate securities litigation reform act

Ultragenyx to Participate in Panel at Citi s 16th Annual

Ultragenyx to Participate in Panel at Citi s 16th Annual
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Joshua higaEmild kakkisUltragenyx pharmaceutical incDrug development strategies for raredisease onContact ultragenyx pharmaceutical incChief executive officerDevelopment strategiesAnnual biopharma healthcare conference